SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 428.40 |
| Enterprise Value ($M) | 383.18 |
| Book Value ($M) | 409.85 |
| Book Value / Share | 6.55 |
| Price / Book | 1.05 |
| NCAV ($M) | 394.65 |
| NCAV / Share | 6.31 |
| Price / NCAV | 1.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.84 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.13 |
| Current Ratio | 9.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 454.48 |
| Assets | 469.67 |
| Liabilities | 59.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 41.24 |
| Operating Income | -410.52 |
| Net Income | -400.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -267.19 |
| Cash from Investing | 266.68 |
| Cash from Financing | 10.66 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 7.20 | -17.92 | |
| 13G | Madison Avenue Partners, LP | 8.00 | ||
| 13G/A | Fmr Llc | 0.80 | -87.83 | |
| 13G/A | Morgan Stanley | 1.60 | -77.72 | |
| 13G/A | Rtw Investments, Lp | 4.90 | -42.23 | |
| 13G/A | Vanguard Group Inc | 7.90 | -16.01 | |
| 13G/A | Bb Biotech Ag | 1.90 | -73.58 | |
| 13D | Biogen Inc. | 10.20 | 0.00 | |
| 13G/A | State Street Corp | 4.80 | -25.32 | |
| 13G/A | Wellington Management Group Llp | 0.07 | -99.34 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 94,157 | 706,634 | 13.32 | |
| 147,065 | 823,989 | 17.85 | |
| 78,247 | 453,440 | 17.26 | |
| 92,817 | 602,655 | 15.40 | |
| 110,769 | 712,350 | 15.55 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNA – Avidity Biosciences, Inc. | RNAC – Cartesian Therapeutics, Inc. |
| RYTM – Rhythm Pharmaceuticals, Inc. | SCYX – SCYNEXIS, Inc. |
| SGMT – Sagimet Biosciences Inc. |
Financial data and stock pages provided by
Fintel.io